Partnering to accelerate anti-cancer drug discovery

A unique collaboration between government, industry and researchers aims to accelerate drug discovery using a new technology platform. Already, the team has identified a potential anti-cancer drug lead targeting the regulator gene cMyc.

The Challenge

Developing therapies for treating cancer

Despite extensive work by industry and researchers, a significant number of highly important cancer targets remain untreatable by drugs.

A key hurdle in the development of new therapies is the identification of promising new molecular starting points.

Melbourne biotech MecRx had an idea for a technological solution to identify novel drug starting points.

Yet, as a start-up company, they lacked the resources and funding to get their idea off the ground.

Our Response

Bringing together minds from across sectors

From left to right: CSIRO's Paul Savage, MecRx's Jo Alcindor and Chris Smith, and CSIRO's Jack Ryan.

With the support of a Victorian Government Technology Voucher, MecRx partnered with us to develop a new technology platform for identifying promising starting points for new anti-cancer drugs.

We shared the research and development costs in return for a mixture of milestone payments and shares in MecRx, based on their success.

The risk-sharing agreement has enabled MecRx to secure a $4 million investment from the Medical Research Commercialisation Fund to advance its breakthrough technology for accelerating drug discovery.

The Results

Putting a new lead to the test

Using the technology platform, the team has identified a potential anti-cancer drug lead for inhibiting the biological target cMyc – a key driver of destructive cell proliferation in many cancers.

MecRx and CSIRO have now joined forces with the world-leading Peter MacCallum Cancer Centre to develop and test the drug lead. If successful, the drug could be tested in cancer patients within a few years.

Our collaborators

Enquiries

Have an enquiry about this page?

Contact us

Do business with us to help your organisation thrive

We partner with small and large companies, government and industry in Australia and around the world.

Contact us now to start doing business